Penetration of colistin into cerebrospinal fluid

Antimicrobial Agents and Chemotherapy

Volumn 53, Issue 11, 2009, Pages 4907-4910

  Markantonis, S L ^a   Markou, N ^b   Fousteri, M ^a   Sakellaridis, N ^b   Karatzas, S ^a   Alamanos, I ^b   Dimopoulou, E ^b   Baltopoulos, G ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b KAT HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

COLISTIMETHATE; LINEZOLID; MEROPENEM; TIGECYCLINE;

ACINETOBACTER INFECTION; ADULT; AGED; ANASTOMOSIS; AREA UNDER THE CURVE; ARTICLE; BLOODSTREAM INFECTION; BRAIN VENTRICULITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG PENETRATION; FEMALE; HUMAN; LUMBAR PUNCTURE; MALE; MAXIMUM PLASMA CONCENTRATION; PRIORITY JOURNAL; STEADY STATE; VENTILATOR ASSOCIATED PNEUMONIA;

ADULT; AGED; ANTI-BACTERIAL AGENTS; COLISTIN; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 70350321271     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00345-09     Document Type: Article

References (16)

1. Andes, D. R., and W. A. Craig. 1999. Pharmacokinetics and pharmacodynamics of antibiotics in meningitis. Infect. Dis. Clin. N. Am. 13:595-618.
2. Benifla, M., G. Zucker, A. Cohen, and M. Alkan. 2004. Successful treatment of Acinetobacter meningitis with intrathecal polymyxin E. J. Antimicrob. Chemother. 54:290-292.
3. Brown, E. M. 2007. Neurosurgical infections in intensive care unit patients, p. 580-594. In J. Rello, M. Kollef, E. Diaz, and A. Rodriguez (ed.), Infectious diseases in critical care, 2nd ed. Springer Publishing Company, New York, NY.
4. de Lange, E. C., and M. Danhof. 2002. Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting. Clin. Pharmacokinet. 41:691-703.
5. Everett, E. D., and L. J. Strausbaugh. 1980. Antimicrobial agents and the central nervous system. Neurosurgery 6:691-714. (Pubitemid 10071706)
6. Falagas, M. E., and S. K. Kasiakou. 2005. Colistin: the revival of polymyxins for the management of multidrug-resistant Gram-negative bacterial infections. Clin. Infect. Dis. 40:1333-1341.
7. Fernandez-Viladrich, P., X. Corbella, L. Corral, F. Tubau, and A. Mateu. 1999. Successful treatment of ventriculitis due to carbapenem-resistant Acinetobacter baumannii with intraventricular colistin sulfomethate sodium. Clin. Infect. Dis. 28:916-917.
8. Jimenez-Mejias, M. E., B. Becerril, F. J. Marquez-Rivas, C. Pichardo, L. Cuberos, and J. Pachon. 2000. Successful treatment of multidrug-resistant Acinetobacter baumannii meningitis with intravenous colistin sulfomethate sodium. Eur. J. Clin. Microbiol. Infect. Dis. 18:970-971.
9. Jimenez-Mejias, M. E., C. Pichardo-Guerrero, F. J. Marquez-Rivas, D. Martin-Lozano, T. Prados, and J. Pachon. 2002. Cerebrospinal fluid penetration and pharmacokinetic/pharmacodynamic parameters of intravenously administered colistin in a case of multidrug-resistant Acinetobacter baumannii meningitis. Eur. J. Clin. Microbiol. Infect. Dis. 21:212-214.
10. Kasiakou, S. K., P. I. Rafailidis, K. Liaropoulos, and M. E. Falagas. 2005. Cure of post-traumatic recurrent multiresistant gram-negative rod meningitis with intraventricular colistin. J. Infect. 50:348-352.
11. Levin, A. S., A. A. Barone, J. Penco, M. V. Santos, I. S. Marinho, E. A. G. Arruda, E. I. Manrique, and S. F. Costa. 1999. Intravenous colistin as therapy for nosocomial infections caused by multidrug resistant Pseudomonas aeruginosa and Acinetobacter baumanii. Clin. Infect. Dis. 28:1008-1011.
12. Li, J., R. L. Nation, J. D. Turnidge, R. W. Milne, K. Coulthard, C. R. Rayner, and D. L. Paterson. 2006. Colistin: the re-emerging antibiotic for multidrugresistant Gram-negative bacterial infections. Lancet Infect. Dis. 6:589-601.
13. Lutsar, I., G. H. McCracken, Jr., and I. R. Friedland. 1998. Antibiotic pharmacodynamics in cerebrospinal fluid. Clin. Infect. Dis. 27:1117-1129.
14. Markou, N., S. L. Markantonis, E. Dimitrakis, D. Panidis, E. Boutzouka, S. Karatzas, P. Rafailidis, H. Apostolakos, and G. Baltopoulos. 2008. Colistin serum concentrations after intravenous administration in critically ill patients with serious multi-drug resistant, Gram-negative bacilli infections: a prospective, open label, uncontrolled study. Clin. Ther. 30:143-151.
15. Nau, R., F. Sorgel, and H. W. Prange. 1998. Pharmacokinetic optimization of the treatment of bacterial central nervous system infections. Clin. Pharmacokinet. 35:223-246.
16. Vasen, W., P. Desmery, S. Ilutovich, and A. Di Martino. 2000. Intrathecal use of colistin. J. Clin. Microbiol. 38:3523.